HFCL Shares Surge 140 in Two Months on Strong Q4 Earnings and Export Order Wins Silver Prices Decline on Wednesday May 27 2026 Dating Startups Innovate to Combat Fake Profiles A Growing Market Trend Indian Markets Open Flat After Monday Rally Crude Oil Surges on USIran Tensions ECB Rate Path May Deepen Stagflation Risks Berenberg Economist Warns Coal India Ltd Reaches New Technical Milestone Market Watchers Eye Potential Breakout Epsilon Energy Ltd EPSN Q1 2026 Earnings Modest Profit Reported as Stock Eases Lower CHCO Q1 2026 Earnings Slight EPS Beat Amid Stable Operations CHCI Q1 2008 Earnings EPS Misses Estimates Sharply Stock Gains Despite Weakness NLY Q1 2026 Earnings Modest EPS Beat as Mortgage REIT Faces Steady Rate Environment INLX Q1 2026 Earnings Significant EPS Miss Amidst Challenging Quarter DOYU Q4 2025 Earnings Earnings Beat Estimates by Wide Margin Revenue Details Pending First Commonwealth Financial FCF Edges Lower Amid Modest Selling Pressure High Roller Technologies ROLR Gains 269 as Stock Bounces from Support Angel Oak Mortgage REIT AOMR Shows Modest Gains Consolidates Near Resistance Boqii Holding BQ Bounces Sharply Potential Breakout Above Resistance Prenetics Global PRE Dips 174 as Stock Hovers Near Key Support Zone Global Infrastructure Funding Doubles in Five Years Japanese Banks Lead the Surge Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings Narrower Net Loss Beats Estimates Amid Pipeline Progress CanFite Biopharma Shares Edge Lower Amid Sector Pressure Holds Near Support AAOI Q1 2026 Earnings EPS Misses Estimates as Stock Rises Despite Wider Loss QNRX Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment IBCP Q1 2026 Earnings EPS Slightly Tops Estimates Stock Edges Higher Pasithea Therapeutics Corp KTTA Q1 2026 Earnings Significant EPS Beat Despite Zero Revenue Oxford Lane Capital Corp Preferred Stock Shares 600 Series 2029 OXLCO Q4 2025 Earnings EPS Misses Estimates Despite Solid Operating Results Sagimet Biosciences Inc Q1 2026 Earnings Narrowed Loss Beats Expectations as Clinical Pipeline Advances KRG Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Holds Steady